Rituximab单抗

Rituximab

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

174722-31-7

中文名称

Rituximab单抗

英文名称

Rituximab

别名

IMMunoglobulin G1,anti-(huMan CD20 (antigen)) (huMan-Mouse Monoclonal IDEC-C2B8 g1-chain), disulfide withhuMan-Mouse Monoclonal IDEC-C2B8 k-chain, diMer;Ig gamma-1 chain C region;Immunoglobulin G1;Hsdb 7455;Immunoglobulin G 1 (human-mouse monoclonal idec-C2B8 gamma1-chain anti-human antigen cd 20), disulfide with human-mouse monoclonal idec-C2B8 kappa-chain, dimer;Mab thera;Mabthera;Rituxan

标准英文名

methyl 3-(3-(N-(4-(1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4]thiazin-7-yl)benzyl)cyclohexanecarboxamido)phenyl)acrylate--methyl 3-(3-(N-(4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)benzyl)cyclohexanecarboxamido)phenyl)acrylate--methyl 3-(3-(N-(4-(3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)benzyl)cyclohexanecarboxamido)phenyl)acrylate--methyl 3-(3-(N-(4-(3,4-dihydro-2H-benzo[b][1,4]thiazin-7-yl)benzyl)cyclohexanecarboxamido)phenyl)acrylate--methyl 3-(3-(N-(4-(quinoxalin-6-yl)benzyl)cyclohexanecarboxamido)phenyl)acrylate--N-(4-(2-methylbenzo[d]oxazol-6-yl)benzyl)-N-(3-(prop-1-en-1-yl)phenyl)cyclohexanecarboxamide--N-(4-(3H-indol-5-yl)benzyl)-N-(3-(prop-1-en-1-yl)phenyl)cyclohexanecarboxamide (1/1/1/1/1/1/1)

分子式

C222H230N14O23S2

分子量

3526.49

精确分子量

3523.67

SMILES

CC=CC1=CC(N(CC2=CC=C(C3=CC4=C(C=C3)N=C(C)O4)C=C2)C(=O)C2CCCCC2)=CC=C1.CC=CC1=CC(N(CC2=CC=C(C3=CC4=C(C=C3)N=CC4)C=C2)C(=O)C2CCCCC2)=CC=C1.COC(=O)C=CC1=CC(N(CC2=CC=C(C3=CC4=C(C=C3)NCCO4)C=C2)C(=O)C2CCCCC2)=CC=C1.COC(=O)C=CC1=CC(N(CC2=CC=C(C3=CC4=C(C=C3)NCCS4(=O)=O)C=C2)C(=O)C2CCCCC2)=CC=C1.COC(=O)C=CC1=CC(N(CC2=CC=C(C3=CC4=C(C=C3)NCCS4)C=C2)C(=O)C2CCCCC2)=CC=C1.COC(=O)C=CC1=CC(N(CC2=CC=C(C3=CC4=C(C=C3)OCCO4)C=C2)C(=O)C2CCCCC2)=CC=C1.COC(=O)C=CC1=CC(N(CC2=CC=C(C3=CC4=NC=CN=C4C=C3)C=C2)C(=O)C2CCCCC2)=CC=C1

标准SMILES

CC1=NC2C=CC(=CC=2O1)C1=CC=C(CN(C2=CC=CC(=C2)C=CC)C(=O)C2CCCCC2)C=C1.COC(=O)C=CC1C=CC=C(C=1)N(CC1=CC=C(C=C1)C1=CC2=NC=CN=C2C=C1)C(=O)C1CCCCC1.COC(=O)C=CC1C=CC=C(C=1)N(CC1=CC=C(C=C1)C1=CC2SCCNC=2C=C1)C(=O)C1CCCCC1.COC(=O)C=CC1C=CC=C(C=1)N(CC1=CC=C(C=C1)C1=CC2=C(C=C1)NCCS2(=O)=O)C(=O)C1CCCCC1.COC(=O)C=CC1C=CC=C(C=1)N(CC1=CC=C(C=C1)C1=CC2OCCOC=2C=C1)C(=O)C1CCCCC1.COC(=O)C=CC1C=CC=C(C=1)N(CC1=CC=C(C=C1)C1=CC2OCCNC=2C=C1)C(=O)C1CCCCC1.CC=CC1C=CC=C(C=1)N(CC1=CC=C(C=C1)C1=CC2CC=NC=2C=C1)C(=O)C1CCCCC1

用途

Treatment of non-Hodgkin's lymphoma (NHL); treatment of chronic lymphocytic leukemia (CLL); treatment of moderate to severe rheumatoid arthritis (RA) in adult patients with inadequate response to one or more TNF antagonists, in combination with methotrexate; treatment of Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA) in adult patients, in combination with glucocorticoids; therapeutic agent for B-cell-mediated autoimmune diseases.

InChIKey

RSEKYLFCZNOVCI-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  174722-31-7 逆合成路线 1

—
—
—
—
ACXTKZ973
174722-31-7
来源: SureRoute

2.  174722-31-7 逆合成路线 2

—
—
ACXTKZ973
174722-31-7
来源: SureRoute

3.  174722-31-7 逆合成路线 3

—
—
—
—
ACXTKZ973
174722-31-7
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手